International journal of radiation oncology, biology, physics
-
To study and report 6 patients with radiation recall in unique sites, secondary to gemcitabine chemotherapy. ⋯ Radiation recall from gemcitabine chemotherapy is rare, but can potentially arise in any site that has been previously irradiated. Treating physicians must be aware of this potential toxicity from gemcitabine and radiation and discontinue the gemcitabine if radiation recall is observed.